Integrated Biopharma Balance Sheet - Quarterly (OTCMKTS:INBP)

Add to My Stocks
$0.18 $0 (0%) INBP stock closing price Sep 19, 2018 (Closing)

The financial analysis of a company like Integrated Biopharma involves checking the three financial statements of the company in detail, of which the balance sheet is one. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Integrated Biopharma stock analysis. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Integrated Biopharma balance sheet as at the end of 2018 Q4 indicates an asset turnover ratio of 2.79 and debt to equity ratio of -. Also check Integrated Biopharma revenue and Integrated Biopharma operating cash flow for the same period.

View and download Integrated Biopharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jul - Jun2018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Marketable Securities----------
Raw Materials4.18M4.43M4.74M3.79M3.84M4.85M4.31M4.7M4.04M4.25M
Work In Progress2.21M1.99M1.94M1.31M1.96M1.12M1.28M1.9M2.21M1.12M
Finished Goods1.36M2.12M1.36M1.93M1.83M1.9M2.22M1.47M1.5M1.44M
Notes Receivable----------
Other Current Assets----------
Total Current Assets
Property Plant & Equipment8.44M8.41M8.47M8.39M8.3M8.3M8.08M8.03M8M7.91M
Accumulated Depreciation6.79M6.74M6.79M6.76M6.7M6.65M6.58M6.5M6.44M6.43M
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable10.16M4.67M4.21M4.46M4.12M4.54M1.49M12.6M11.74M7.45M
Accounts Payable4.18M4.87M5.55M3.72M4.17M4.67M5.63M4.82M5.46M6.05M
Current Portion Long-Term Debt---1.03M1.11M1.03M----
Current Portion Capital Leases----------
Accrued Expenses1.06M1.26M1.31M1.2M1.18M1.12M1.4M1.11M1.21M1.2M
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt-5.25M5.24M5.23M5.22M5.23M5.22M5.21M5.2M5.19M
Long-Term Debt3.62M3.72M3.88M3.76M4.24M4.6M4.7M4.87M5.3M5.55M
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus44.77M44.77M44.76M44.76M44.75M44.74M44.73M44.71M44.7M44.69M
Retained Earnings-49.95M-50.77M-51.15M-50.81M-50.63M-52.16M-52.4M-52.32M-52.97M-53.72M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity-5.24M-6.05M-6.44M-6.1M-5.92M-7.47M-7.73M-7.67M-8.32M-9.08M
Total Liabilities & Shareholders Equity14.57M14.62M15.64M13.38M15.19M13.61M14.99M14.64M14.08M14.11M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Integrated Biopharma historical stock prices and the current Integrated Biopharma stock price can tell you how the stock price has moved, whereas the Integrated Biopharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the Integrated Biopharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Integrated Biopharma had total assets of $14.57M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. INBP stock had total liabilities of $19.8M for the quarter 2018 Q4.

Integrated Biopharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover